gms | German Medical Science

57th Annual Meeting of the German Society of Neurosurgery
Joint Meeting with the Japanese Neurosurgical Society

German Society of Neurosurgery (DGNC)

11 - 14 May, Essen

Paradigm shift in Neuroendovascular Therapy to tailor-made treatment of cerebrovascular disease

Meeting Abstract

Search Medline for

  • corresponding author A. Takahashi - Department of Neuroendovascular Therapy, Tohoku University School of Medicine, Sendai, Japan

Deutsche Gesellschaft für Neurochirurgie. Japanische Gesellschaft für Neurochirurgie. 57. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. Essen, 11.-14.05.2006. Düsseldorf, Köln: German Medical Science; 2006. DocSO.02.08

The electronic version of this article is the complete one and can be found online at:

Published: May 8, 2006

© 2006 Takahashi.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Objective: To address several aspects of a break-through in the field of Neuroenodvascular Therapy for truly patient-based/specific tailor-made treatment.

Methods: Despite the rapid development of tools and techniques during past 10 years, the maturation of Neuroendovascular Therapy still remains primitive. One of the main reasons for this maybe related to the fact that the strategy of the treatment is not completely based on the patient-specific data, despite the development of 3D (or 4D) data set available tody. We have developed the methods for this paradigm shift including categorization of brain aneurysms based on computer fluid dynamics (CFD) (J Neurosurg 103:662,2005). A significant number of projects which require concentrated innovations including the design, application and monitoring of the efficacy of new therapeutic method should be carried out. However this would open the new horizon to better patient management.

Results: Patient specific preparation of Neuroendovascular Therapy based on 3D (or 4D) data set. Brain aneurysm and carotid atherosclerotic lesions, for example, would be presented.

Conclusions: Paradigm shift brought by patient-specific management in the field of Neuroendovascular Therapy appears to be a promising way of revolutionizing the way of treatment in cerebrovascular disease.